Skip to main content
Top

Breast Cancer Research and Treatment

Issue 3/2002

Content (10 Articles)

Prognostic Value of Thermographical Findings in Patients with Primary Breast Cancer

Shozo Ohsumi, Shigemitsu Takashima, Kenjiro Aogi, Hisashi Usuki

Potential Mouse Tumor Model for Pre-Clinical Testing of Mage-Specific Breast Cancer Vaccines

Roza K. Sypniewska, Lieve Hoflack, David J. Bearss, Claudia Gravekamp

The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer

Marilie D. Gammon, Alfred I. Neugut, Regina M. Santella, Susan L. Teitelbaum, Julie A. Britton, Mary Beth Terry, Sybil M. Eng, Mary S. Wolff, Steven D. Stellman, Geoffrey C. Kabat, Bruce Levin, H. Leon Bradlow, Maureen Hatch, Jan Beyea, David Camann, Martin Trent, Ruby T. Senie, Gail C. Garbowski, Carla Maffeo, Pat Montalvan, Gertrud S. Berkowitz, Margaret Kemeny, Marc Citron, Freya Schnabel, Allan Schuss, Steven Hajdu, Vincent Vincguerra, Gwen W. Collman, G. Iris Obrams

Association Between Nitrotyrosine Levels and Microvascular Density in Human Breast Cancer

Michael Samoszuk, Marie-Luise Brennan, Vu To, Leonard Leonor, Lemin Zheng, Xiaoming Fu, Stanley L. Hazen

Authors Index

Author index, Volume 74

Subject Index

Subjec index, volume 74

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine